We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Antiviral Effects of TXA as a Preventative Treatment Following COVID-19 Exposure (TXACOVIDPREV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04550338
Recruitment Status : Withdrawn (With vaccination efforts ongoing, a feasibility survey indicated there would be inadequate recruitment)
First Posted : September 16, 2020
Last Update Posted : April 23, 2021
Sponsor:
Information provided by (Responsible Party):
Timothy Ness, MD, University of Alabama at Birmingham

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : December 31, 2022
Estimated Study Completion Date : March 31, 2023